<DOC>
	<DOCNO>NCT00730665</DOCNO>
	<brief_summary>To understand dose-response characteristic PF-00885706 efficacy term symptomatic relief use add-on treatment esomeprazole 20mg ( standard proton pump inhibitor [ PPI ] treatment ) , subject gastro-esophageal reflux ( GERD ) inadequate relief PPIs .</brief_summary>
	<brief_title>Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Subjects diagnosis GERD fulfill follow criterion : symptom least six month prior enrollment ; currently daily treatment PPI treatment least 3 month ; whose symptom persistent , troublesome include heartburn and/or regurgitation predominant symptom despite treatment PPI ; seek relief persistent symptom . Subjects erosive esophagitis An endoscopy within last 5 year require verify absence . Subjects esophageal gastric diseases/conditions may contribute GERD symptom . If female ; pregnant , lactate positive serum urine pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>PPI partial responder non-erosive GERD .</keyword>
</DOC>